Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

To develop and measure the effects of a culturally sensitive yoga program for inpatients

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Cancer patients scheduled to undergo an autologous or allogeneic HSCT at MD Anderson, HCG, or MNH;

Age 18 or older;

English, Hindi, or Swahili speaking;

Able to sign a written informed consent and be willing to follow protocol requirements.

Disqualifiers

Extreme mobility issues that preclude participating in the YT;

Major thought disorders such as schizophrenia or uncontrolled bipolar disorder;

HCT comorbidity score of 3 or higher, excluding cancer diagnoses

Trial design

Design model

Single group

Treatments tested in this trial

  • Yoga Sessions

    Behavioral

    Participants will have up to 12 sessions, 3 sessions per week starting two weeks before the transplant and throughout the first 30 days of your hospitalization.

  • Questionnaries

    Behavioral

    Participants will complete 4 questionnaires about any symptoms you may be having, any anxiety and/or depression you may be having, your quality of life, and your expectations about your treatment.

  • Interviews

    Behavioral

    Participants will have an exit interview last about 30-45 minutes. The interview will be conducted over the phone or remotely over Zoom, FaceTime, or other approved video call methods.). The interview will be audio and video recorded and transcribed (typed).

Treatment groups

60 Participants
are divided into 1 treatment group
Group A: Yoga SessionsExperimental treatment 3 interventions

Trial outcomes

Primary outcomes

1

Patient Health Questionnaire-8 (PHQ-8)

The PHQ-8 is a 8-item self-report questionnaire used to assess bother of depressive symptoms over the past 2 weeks. The PHQ-8 is a 8-item questionnaire to screen for degree of depressive symptoms scored on a 0-24 scale with higher scores indicating greater distress and impairment

Time frame
through study completion; an average of 1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

M.D. Anderson Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator